Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

High-Fat Meals Could Be More Harmful To Males Than Females, According To New Obesity Research, Cedars-Sinai Medical Center Reveals

October 23, 2014 – 5:00 am | Edit Post

High-Fat Meals Could Be More Harmful To Males Than Females, According To New Obesity ResearchLos Angeles – Oct. 16, 2014 Male and female brains are not equal when it comes to the biological response to a high-fat diet. Cedars-Sinai Diabetes and…

OSI Systems, Inc. Reports First Quarter Fiscal 2015 Financial Results

October 23, 2014 – 5:00 am | Edit Post

OSI Systems, Inc. (NASDAQ: OSIS) today announced financial results for the quarter ended September 30, 2014. Deepak Chopra, OSI Systems Chairman and CEO, stated, We are pleased to report solid first quarter performance which delivered record-breaking revenue, earnings and free cash flow providing a strong start to our fiscal year. Led by our Security division, our non-GAAP earnings increased…

Flint Rehabilitation Devices Introduces MusicGlove, World???s First FDA Approved, Clinically Validated Music-Based Hand Rehabilitation Device

October 23, 2014 – 5:00 am | Edit Post

IRVINE, Calif.–(BUSINESS WIRE)–Flint Rehabilitation Devices today introduced MusicGlove (#musicglove), the worlds first FDA approved, clinically validated hand rehabilitation (#rehabilitation) device that uses music and gaming to make therapy (#therapy) fun and effective for the over six million people with stroke or other neurological or muscular injuries. The device, which helps increase users…

TearLab Corporation To Release Q3 2014 Financial Results On November 5, 2014

October 23, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 22, 2014 (GLOBE NEWSWIRE) — TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) (“TearLab” or the “Company”) expects to announce its Q3 2014 financial results after market closes on Wednesday November 5, 2014. TearLab is pleased to invite all willing participants in a conference call during…

Flint Rehabilitation Devices Introduces MusicGlove, World???s First FDA Approved, Clinically Validated Music-Based Hand Rehabilitation Device

October 23, 2014 – 5:00 am | Edit Post

IRVINE, Calif.–(BUSINESS WIRE)–Flint Rehabilitation Devices today introduced MusicGlove (#musicglove), the worlds first FDA approved, clinically validated hand rehabilitation (#rehabilitation) device that uses music and gaming to make therapy (#therapy) fun and effective for the over six million people with stroke or other neurological or muscular injuries. The device, which helps increase users…

Rich Pharmaceuticals Announces Submission Of Investigational New Drug (IND) Application To FDA For The Treatment Of Acute Myelocytic Leukemia And Myelodysplastic Syndrome

October 23, 2014 – 5:00 am | Edit Post

BEVERLY HILLS, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) — Rich Pharmaceuticals, Inc. (OTCQB:RCHA) (“Rich” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies in oncology, announced today that it has submitted an investigational new drug (IND) application…

Reflow Wins FDA Approval And Initial US Clinical Use Of The Wingman35 Crossing Catheter

October 23, 2014 – 5:00 am | Edit Post

Reflow Medical Corporation Announces FDA 510(K) Clearance And Initial US Clinical Use Of The Wingman35 Crossing CatheterSAN CLEMENTE, Calif.–(BUSINESS WIRE)–ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their Wingman35 Crossing Catheter for use in the peripheral vasculature as well as the first US clinical cases with…

MediciNova, Inc. Announces FDA Granted Orphan Drug Designation To MN-001 (Tipelukast) For Idiopathic Pulmonary Fibrosis (IPF)

October 23, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 22, 2014 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that the U.S. Food and Drug Administration (FDA) has granted orphan…

A new chink in HIV-1′s armor

October 22, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

A new dent in HIV-1′s armor

October 22, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.